Last reviewed · How we verify

CLS006 Vehicle

Maruho Co., Ltd. · Phase 3 active Small molecule

CLS006 Vehicle is a topical formulation vehicle designed to enhance drug delivery and penetration through the skin.

CLS006 Vehicle is a topical formulation vehicle designed to enhance drug delivery and penetration through the skin. Used for Vehicle formulation for topical dermatological agents (specific indication depends on active drug).

At a glance

Generic nameCLS006 Vehicle
SponsorMaruho Co., Ltd.
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

As a vehicle formulation rather than an active pharmaceutical ingredient, CLS006 Vehicle serves as the carrier system for topical drugs, optimizing their absorption and bioavailability at the site of application. The specific composition and mechanism depend on the active drug being delivered, but the vehicle itself is engineered to improve stability, spreadability, and transdermal or transepidermal penetration.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results